Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry

医学 银屑病性关节炎 类风湿性关节炎 强直性脊柱炎 贾纳斯激酶 银屑病 抗风湿药 持久性(不连续性) 关节炎 肿瘤坏死因子α 内科学 皮肤病科 肿瘤科 免疫学 受体 岩土工程 工程类
作者
Blanca Hernández‐Cruz,Lucia Otero Varela,Mercedes Freire-González,Noemí Busquets-Pérez,A González,Manuel José Moreno Ramos,J. M. Blanco-Madrigal,Sara Manrique‐Arija,Eva Pérez‐Pampín,D. Ruiz-Montesinos,Fernando Sánchez‐Alonso,Carlos Sánchez‐Piedra,Isabel Castrejón
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:: ard-225271 被引量:3
标识
DOI:10.1136/ard-2023-225271
摘要

Objectives To compare the safety of Janus kinase inhibitors (JAKi) with that of tumour necrosis factor inhibitors (TNFi) and determine drug persistence among patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA). Methods We analysed data from patients included in BIOBADASER 3.0 and treated with JAKi or TNFi from 2015 to 2023 and estimated the incidence rate ratio (IRR) of adverse events and persistence. Results A total of 6826 patients were included. Of these, 52% had RA, 25% psoriatic arthritis and 23% axial SpA. Treatment was with TNFi in 86%. The mean duration of treatment was 2.2±2.0 years with TNFi versus 1.8±1.5 with JAKi. JAKis were prescribed in older patients with longer term disease, greater comorbidity and later treatment lines and more frequently as monotherapy. The IRR of all infections and gastrointestinal events was higher among patients with RA treated with JAKi. Drug persistence at 1, 2 and 3 years was 69%, 55% and 45% for TNFi and 68%, 54% and 45% for JAKi. Multivariate regression models showed a lower probability of discontinuation for JAKi (HR=0.85; 95% CI 0.78–0.92) and concomitant conventional synthetic disease-modifying antirheumatic drugs (HR=0.90; 95% CI 0.84–0.96). The risk of discontinuation increased with glucocorticoids, comorbidities, greater disease activity and later treatment lines. Conclusions Infections, herpes zoster and gastrointestinal adverse events in patients with RA tended to be more frequent with JAKi. However, prognosis was poor in patients receiving JAKi. Persistence was similar for TNFi and JAKi, although factors associated with discontinuation differed by diagnostic group.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
丝丢皮得完成签到 ,获得积分10
5秒前
爆米花应助DeepLearning采纳,获得10
9秒前
铜豌豆完成签到 ,获得积分10
9秒前
cheng完成签到,获得积分10
16秒前
君看一叶舟完成签到 ,获得积分10
22秒前
在水一方应助科研通管家采纳,获得10
22秒前
23秒前
Chuang完成签到 ,获得积分10
37秒前
热心市民完成签到 ,获得积分10
42秒前
吃不胖的魔芋丝完成签到 ,获得积分10
50秒前
53秒前
李东东完成签到 ,获得积分10
53秒前
fsznc1完成签到 ,获得积分0
1分钟前
年轻的笙完成签到,获得积分10
1分钟前
嘻嘻完成签到 ,获得积分10
1分钟前
huiluowork完成签到 ,获得积分10
1分钟前
1分钟前
拾陆发布了新的文献求助10
1分钟前
乔杰完成签到 ,获得积分10
1分钟前
ramsey33完成签到 ,获得积分10
1分钟前
小静完成签到 ,获得积分10
1分钟前
默笙完成签到 ,获得积分10
1分钟前
小乙猪完成签到 ,获得积分0
1分钟前
赵帅完成签到 ,获得积分10
1分钟前
1分钟前
西扬完成签到 ,获得积分10
1分钟前
1分钟前
Ray完成签到 ,获得积分10
1分钟前
yyds完成签到,获得积分10
1分钟前
DeepLearning发布了新的文献求助10
1分钟前
1分钟前
柚C美式完成签到 ,获得积分10
1分钟前
kumo完成签到 ,获得积分10
1分钟前
旺旺大礼包完成签到,获得积分10
1分钟前
小康学弟完成签到 ,获得积分10
1分钟前
大个应助DeepLearning采纳,获得10
1分钟前
yimiyangguang完成签到 ,获得积分10
2分钟前
HHEHK完成签到 ,获得积分10
2分钟前
CCsci完成签到 ,获得积分10
2分钟前
ranj完成签到,获得积分10
2分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990835
求助须知:如何正确求助?哪些是违规求助? 3532241
关于积分的说明 11256614
捐赠科研通 3271100
什么是DOI,文献DOI怎么找? 1805229
邀请新用户注册赠送积分活动 882302
科研通“疑难数据库(出版商)”最低求助积分说明 809236